Carbamazepine

INDICATIONS

FDA

  • Bipolar 1 disorder (acute manic or mixed episodes), epilepsy (partial, generalized tonic-clonic and mixed seizures), trigeminal/glossopharyngeal neuralgia

NON-FDA APPROVED USES

  • Aggression, impulse-control disorders, neuropathic pain

There's more to see -- the rest of this topic is available only to subscribers.

Last updated: August 29, 2025